期刊文献+

原发性高血压病人血清胃蛋白酶原水平的变化探讨

Change of serum pepsinogen level in patients with primary hypertension
下载PDF
导出
摘要 目的:探讨原发性高血压病人血清胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)水平及两者比值的变化。方法:选择原发性高血压住院病人107例进行空腹采集静脉血,采用酶联免疫法定量检测血清PGⅠ和PGⅡ浓度水平,比较2组PG结果差异。结果:单纯原发性高血压组和高血压合并胃炎组病人血清PGⅠ和PGⅡ水平明显高于对照组(P <0. 01);而2组病人血清PGⅠ和PGⅡ比值与对照组相比,差异均无统计学意义(P> 0. 05)。结论:血清PGⅠ和PGⅡ浓度水平明显升高,提示临床医生在排除胃部疾病的情况下,可能与原发性高血压的发生有关。 Objective: To investigate the changes of serum levels of pepsinogen Ⅰ and pepsinogen Ⅱ,and its ratio in patients with primary hypertension. Methods: The serum levels of pepsinogen Ⅰ and pepsinogen Ⅱ of fasting venous blood in 107 patients with primary hypertension were detected using enzyme-linked immunosorbent assay,and the difference of which between two groups was compared. Results: The serum levels of pepsinogen Ⅰ and pepsinogen Ⅱ in patients with primary hypertension were significantly higher than those in control group( P〈0. 01). The difference of the ratio of pepsinogen Ⅰ and pepsinogen Ⅱ between two groups was not statistically significant( P〈0. 05). Conclusions: The serum levels of pepsinogen Ⅰ and pepsinogen Ⅱ in patients with primary hypertension significantly increase,which may be related to the primary hypertension under excluding stomach diseases.
作者 梁友宝 王中安 常滋毓 吴珊珊 衡二虎 LIANG You-bao;WANG Zhong-an;CHANG Zi-yu;WU Shan-shan;HENG Er-hu(Department of Laboratory,The First People's Hospital of Bengbu,Bnegbu Anhui 233000,China)
出处 《蚌埠医学院学报》 CAS 2018年第11期1499-1500,1504,共3页 Journal of Bengbu Medical College
基金 安徽省蚌埠市科技局指导项目(20160311)
关键词 高血压 胃蛋白酶原 hypertension pepsinogen
  • 相关文献

参考文献5

二级参考文献44

  • 1张杰,王冬娥,米贤军,郭瑛.消化性溃疡幽门螺杆菌(Hp)清除前后血Hp抗体、PG、GAS变化的研究[J].临床和实验医学杂志,2006,5(7):869-871. 被引量:5
  • 2孙丽萍,宫月华,王兰,董明,袁媛.辽宁庄河地区居民血清胃蛋白酶原含量检测分析[J].中华消化杂志,2006,26(10):649-652. 被引量:37
  • 3陈卫中,潘晓平,倪宗瓒.logistic回归模型在ROC分析中的应用[J].中国卫生统计,2007,24(1):22-24. 被引量:56
  • 4中国高血压防治指南修订委员会.中国高血压防治指南2010.中华高血压杂志,201 1. 被引量:38
  • 5ShafaghiA,Mansour-GhanaeiF,JoukarF,etal.Serum gastrinandthepepsinogenⅠ/Ⅱ ratioasmarkersfordiagnosisofpremalignantgastriclesions[J].AsianPacJCancerPrev,2013,14(6):3931-3936. 被引量:1
  • 6ToyodaK,FurusyoN,IharaT,etal.Serumpepsinogen and Helicobacter pylori infection-aJapanesepopulationstudy[J].EurJClinMicrobiolInfectDis,2012,31(9):2117-2124. 被引量:1
  • 7HuangM,TangAG,MuS,,etal.SerumpepsinogenreferenceintervalsinapparentlyhealthyChinesepopulationwithlatexenhancedturbidimetricimmunoassay[J].ClinPathol,2014,67(4):350-354. 被引量:1
  • 8WatanabeM,KatoJ,InoueI,etal.Developmentofgastriccancerinnonatrophicstomachwithhighlyactiveinflammation identified byserum levelsofpepsinogenandHelicobacterpyloriantibodytogetherwithendoscopicrugalhyperplasticgastritis[J].IntJCancer,2012,131(11):2632-2642. 被引量:1
  • 9SurianiR, VenturiniI, ColozzaM, etal.Helicobacterpyloriantibodies(CagA and VacA)detection.Thelinkbetweencancerandinfection[J].MinervaGastroenterolDietol,2002,48(2):1591-1564. 被引量:1
  • 10ShiotaS,MurakamiK,OkimotoT,etal.SerumHelicobacterpyloriCagA antibodytiterasausefulmarkerforadvancedinflammationinthestomachinJapan[J].JGastroenterolHepatol,2014,29(1):67-73. 被引量:1

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部